endocrine status
Showing 1 - 25 of >10,000
HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving
Completed
- Breast Neoplasms
- NET or NCT
-
Haidian, Beijing, ChinaPeking University Cancer Hospital
Dec 30, 2022
Pelvic Surgery, Routine Fallopian Tube Removal Trial in Baden, Bern (Routine fallopian tube removal)
Recruiting
- Pelvic Surgery
- Routine Fallopian Tube Removal
- Routine fallopian tube removal
-
Baden, Switzerland
- +1 more
Sep 29, 2021
![](/image/sponsor/kazakhstan's_medical_university_"ksph")
Health Status of Children Born After Assisted Reproductive
Recruiting
- Children Born After Assisted Reproductive Technologies
- +2 more
- hemogram examination
-
Almaty, KazakhstanSevara ilmuratova
Oct 17, 2023
Molecular, Metabolomic and Nutritional Changes After Metabolic
Recruiting
- Obesity; Endocrine
- +2 more
-
Shah Alam, Selangor, MalaysiaInstitute for Medical Research, National Institutes of Health
Aug 29, 2022
Polycystic Ovary Syndrome, Insulin Resistance, Vitamin D Deficiency Trial in London
Suspended
- Polycystic Ovary Syndrome
- +3 more
-
London, United KingdomSt George's Hospital Trust
May 21, 2021
Infectious Disease, Tumors, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism
Recruiting
- Infectious Disease
- +20 more
-
Arlington Heights, IllinoisAnova Enterprises, Inc.
May 13, 2022
Hormonal Status and Quality of Life in Female Postmenopausal
Completed
- Burning Mouth Syndrome
- +5 more
- unstimulated saliva sample for hormone analysis
- quality of life questionnaire
-
Zagreb, CroatiaSchool of Dental Medicine, University of Zagreb
Sep 1, 2020
Hormone Disturbance Trial
Completed
- Hormone Disturbance
- (no location specified)
Jun 23, 2020
"Iron Overload and Endocrinological Diseases"
Recruiting
- Iron Overload
- +4 more
-
Modena, ItalyUnit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
Nov 13, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Breast Cancer, Hot Flash Due to Medication Trial (Oxybutynin, Venlafaxine)
Not yet recruiting
- Breast Cancer
- Hot Flash Due to Medication
- (no location specified)
Oct 24, 2023
Maternal Endocrine System and Metabolic Diseases and Offspring
Not yet recruiting
- Thyroid Dysfunction
- Diabetes Mellitus
- (no location specified)
Jul 17, 2023
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)
Not yet recruiting
- Breast Neoplasms
- Disitamab Vedotin
- Toripalimab
-
Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
- +2 more
Oct 23, 2023
Metabolism Disorder, Nutrition Trial in Nanjing (Macronutrients, Mixed meal tolerance test (MMTT))
Not yet recruiting
- Metabolism Disorder
- Nutrition
- Macronutrients
- Mixed meal tolerance test (MMTT)
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital, Nanjing Medical University
Mar 13, 2023
Metastatic Breast Cancer Trial in Spain (Palbociclib, Trastuzumab, Endocrine therapy)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +4 more
-
Badalona, Barcelona, Spain
- +34 more
Oct 24, 2022
Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)
Recruiting
- Breast Cancer
- Dalpiciclib
- +4 more
-
Shijiazhuang, Hebei, ChinaThe Fourth Hospital of Hebei Medical University
Oct 25, 2023
Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)
Recruiting
- Hormone Receptor Positive Breast Carcinoma
- +6 more
- Liquid biopsy and CT scan
-
Bergame, Bergamo, Italy
- +6 more
Apr 13, 2023
Standardized Diagnosis and Treatment of Endocrine Hypertension
Recruiting
- Endocrine Hypertension
- Standardized diagnosis and treatment
-
Nantong, Jiangsu, ChinaGu Yunjuan
Dec 12, 2021
Brain Health in Breast Cancer Survivors
Recruiting
- Cognitive Impairment
- Cognitive Function
-
Los Angeles, CaliforniaUniversity of California at Los Angeles
Mar 9, 2022
Breast Cancer Trial in Oslo, Trondheim (Aromatase Inhibitor, Bevacizumab, Epirubicine)
Completed
- Breast Cancer
- Aromatase Inhibitor
- +6 more
-
Oslo, Norway
- +2 more
Jan 5, 2023
PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic
Recruiting
- Frailty
-
Florence, Italy
- +4 more
Nov 22, 2022
